An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy

NCT00191646 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

919

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Neoplasms, Female
Fallopian Tube Neoplasms
Ovarian Neoplasms
Pelvic Neoplasms
Peritoneal Neoplasms

Interventions

DRUG: Gemcitabine
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Eli Lilly and Company